Nexus Surgical and Medicare Limited Share Price

Equities

NEXUSSURGL

INE370Q01015

Medical Equipment, Supplies & Distribution

Delayed Bombay S.E. 07:45:00 02/07/2024 BST 5-day change 1st Jan Change
13.56 INR -4.91% Intraday chart for Nexus Surgical and Medicare Limited +1.19% +17.40%

Financials

Sales 2022 23.95M 287K 22.7M Sales 2023 15.53M 186K 14.72M Capitalization 47.33M 567K 44.85M
Net income 2022 2M 23.95K 1.9M Net income 2023 1M 11.98K 948K EV / Sales 2022 1.66 x
Net cash position 2022 1.5M 18K 1.42M Net cash position 2023 6.94M 83.07K 6.57M EV / Sales 2023 2.6 x
P/E ratio 2022
14.2 x
P/E ratio 2023
27.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 32.01%
More Fundamentals * Assessed data
Dynamic Chart
Nexus Surgical and Medicare Limited Appoints Ashish Durgaprasad Mishra as Additional Director - Non- Executive Professional Director CI
Nexus Surgical and Medicare Limited Appoints Surya Kant Modi as Additional Director - Independent Non-Executive Director CI
Nexus Surgical and Medicare Limited Announces Cessation of Avanish Kumar Ardawatia as Independent Director of the Company CI
Nexus Surgical and Medicare Limited Announces Cessation of Rajesh Babulal Sodani as Independent Director of the Company CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Nexus Surgical and Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Nexus Surgical and Medicare Limited Appoints Ram Swaroop Mahadev Joshi as Managing Director CI
Nexus Surgical and Medicare Limited Appoints Pawankumar Sitaram Choudhary as Director CI
Nexus Surgical and Medicare Appoints New Managing Director, CFO MT
More news
1 day-4.91%
1 week+1.19%
Current month-4.78%
1 month-19.76%
3 months-3.62%
6 months+19.79%
Current year+17.40%
More quotes
1 week
12.91
Extreme 12.91
14.27
1 month
12.91
Extreme 12.91
18.30
Current year
10.43
Extreme 10.43
18.30
1 year
8.10
Extreme 8.1
18.30
3 years
2.28
Extreme 2.28
18.30
5 years
2.28
Extreme 2.28
18.30
10 years
2.28
Extreme 2.28
64.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 13/11/16
Director of Finance/CFO 69 12/08/22
Compliance Officer - 03/01/15
Members of the board TitleAgeSince
Director of Finance/CFO 69 12/08/22
Chief Executive Officer 62 13/11/16
Director/Board Member 26 29/06/21
More insiders
Date Price Change Volume
02/07/24 13.56 -4.91% 2 083
01/07/24 14.26 +0.14% 2,989
28/06/24 14.24 +4.94% 342
27/06/24 13.57 +4.95% 874
26/06/24 12.93 -3.51% 1,666

Delayed Quote Bombay S.E., July 02, 2024 at 07:45 am

More quotes
Nexus Surgical and Medicare Limited is an India-based company, which is engaged in the trading business. The Company is involved in importing and marketing surgical and pharmaceutical products. The Company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various sizes used for storage of sterilized equipment and material.
More about the company
  1. Stock Market
  2. Equities
  3. NEXUSSURGL Stock